NO842962L - Fremgangsmaate for fremstilling av et polypeptid egnet for anvendelse i en vaksinasjonsprosedyre - Google Patents

Fremgangsmaate for fremstilling av et polypeptid egnet for anvendelse i en vaksinasjonsprosedyre

Info

Publication number
NO842962L
NO842962L NO842962A NO842962A NO842962L NO 842962 L NO842962 L NO 842962L NO 842962 A NO842962 A NO 842962A NO 842962 A NO842962 A NO 842962A NO 842962 L NO842962 L NO 842962L
Authority
NO
Norway
Prior art keywords
procedure
preparing
vaccination
polypeptide suitable
polypeptide
Prior art date
Application number
NO842962A
Other languages
English (en)
Other versions
NO172745B (no
NO172745C (no
Inventor
Gary H Cohen
Rosely J Eisenberg
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26996451&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO842962(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO842962L publication Critical patent/NO842962L/no
Application filed by University Patents Inc filed Critical University Patents Inc
Publication of NO172745B publication Critical patent/NO172745B/no
Publication of NO172745C publication Critical patent/NO172745C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/224—Herpes related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO84842962A 1982-02-18 1984-07-19 Analogifremgangsmaate for fremstilling av et herpes simplex viruspolypeptid egnet for anvendelse i en vaksinasjonsprosess NO172745C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35002182A 1982-02-18 1982-02-18
US06/463,141 US4762708A (en) 1982-02-18 1983-02-04 Materials and methods for herpes simplex virus vaccination

Publications (3)

Publication Number Publication Date
NO842962L true NO842962L (no) 1983-10-17
NO172745B NO172745B (no) 1993-05-24
NO172745C NO172745C (no) 1993-09-01

Family

ID=26996451

Family Applications (2)

Application Number Title Priority Date Filing Date
NO83833773A NO162366B (no) 1982-02-18 1983-10-17 Fremgangsmaate for isolering av et immunogent preparat av herpes simplex virus type 1 glykoprotein gd-1 eller herpersimplex virus type 2 glykoprotein gd-2 fra en vaeskeproeve.
NO84842962A NO172745C (no) 1982-02-18 1984-07-19 Analogifremgangsmaate for fremstilling av et herpes simplex viruspolypeptid egnet for anvendelse i en vaksinasjonsprosess

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO83833773A NO162366B (no) 1982-02-18 1983-10-17 Fremgangsmaate for isolering av et immunogent preparat av herpes simplex virus type 1 glykoprotein gd-1 eller herpersimplex virus type 2 glykoprotein gd-2 fra en vaeskeproeve.

Country Status (20)

Country Link
US (1) US4762708A (no)
EP (1) EP0101506B1 (no)
JP (3) JP2665332B2 (no)
KR (1) KR910006889B1 (no)
AR (1) AR231496A1 (no)
AT (1) ATE54827T1 (no)
AU (1) AU554710B2 (no)
CA (1) CA1236774A (no)
DE (1) DE3381761D1 (no)
DK (1) DK172619B1 (no)
ES (1) ES519875A0 (no)
FI (2) FI73885C (no)
GR (1) GR77900B (no)
HU (1) HU195734B (no)
IE (1) IE56479B1 (no)
IL (5) IL67930A (no)
NO (2) NO162366B (no)
NZ (1) NZ220771A (no)
PH (1) PH25689A (no)
WO (1) WO1983002897A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540669A (en) * 1980-09-11 1985-09-10 Merck & Co., Inc. Herpes simplex type I subunit vaccine
US5149660A (en) * 1982-02-18 1992-09-22 University Patents, Inc. Diagnostic reagents relating to herpes simplex virus
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
JPS6051120A (ja) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニットワクチン
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
DE3683688D1 (de) * 1985-04-19 1992-03-12 Wistar Inst Impfstoff fuer die erzeugung einer gegen ein virus schuetzenden immunogenen t-zellen-antwort.
GB8605390D0 (en) * 1986-03-05 1986-04-09 Univ Birmingham Live herpes simplex vaccine
EP0471778A1 (en) * 1989-05-12 1992-02-26 Ciba Corning Diagnostics Corp. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US5654174A (en) * 1995-07-07 1997-08-05 Competitive Technologies, Inc. Herpes simplex virus glycoprotein D variants
US20020090382A1 (en) * 2000-08-01 2002-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Antiviral compounds and methods
US20030219448A1 (en) * 2002-05-24 2003-11-27 Cedars-Sinai Medical Center Peptide epitope-based vaccine for treating herpes simplex virus infections and related diseases
US7078041B2 (en) 2002-07-18 2006-07-18 University Of Washington Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same
CA2538794C (en) * 2003-09-12 2016-04-19 Antigenics, Inc. Vaccine for treatment and prevention of herpes simplex virus infection
US8865185B2 (en) * 2006-09-08 2014-10-21 The Trustees Of The University Of Pennsylvania Methods of use for HSV-1 and HSV-2 vaccines
EP2059255A4 (en) * 2006-09-08 2011-08-31 Univ Pennsylvania VACCINES AGAINST HSV-1 AND HSV-2 AND METHODS OF USE
US10478490B2 (en) * 2006-12-28 2019-11-19 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US8057804B2 (en) * 2006-12-28 2011-11-15 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US20130028925A1 (en) * 2006-12-28 2013-01-31 Harvey Friedman Herpes simplex virus combined subunit vaccines and methods of use thereof
CN101616688B (zh) * 2006-12-28 2013-12-11 宾夕法尼亚大学理事会 单纯疱疹病毒联合亚单位疫苗及其使用方法
WO2011106607A2 (en) 2010-02-26 2011-09-01 Juvaris Biotherapeutics, Inc. Subunit vaccines for herpes viruses and methods of use
WO2012139106A2 (en) * 2011-04-08 2012-10-11 Duke University Herpes simplex virus
US9555099B2 (en) 2012-05-16 2017-01-31 Immune Design Corp. Vaccines for HSV-2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
DK171727B1 (da) * 1978-12-22 1997-04-14 Biogen Inc Rekombinante hepatitis B virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenspecifikke polypeptider, DNA-sekvenser kodende for HBV-antigenspecifikke polypeptider, metoder til påvisning af hepatitis B virus-antistoffer, metoder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider og midler til påvisning af HBV-infektion

Also Published As

Publication number Publication date
DK479083A (da) 1983-10-17
NZ220771A (en) 1990-09-26
IL67930A0 (en) 1983-06-15
NO172745B (no) 1993-05-24
NO162366B (no) 1989-09-11
KR910006889B1 (ko) 1991-09-10
NO833773L (no) 1983-10-17
FI83880C (fi) 1991-09-10
AR231496A1 (es) 1984-12-28
HU195734B (en) 1988-07-28
JP2665332B2 (ja) 1997-10-22
JPS59500216A (ja) 1984-02-16
FI833768A0 (fi) 1983-10-17
CA1236774A (en) 1988-05-17
JPH0769924A (ja) 1995-03-14
JP2669594B2 (ja) 1997-10-29
FI864102A (fi) 1986-10-10
AU554710B2 (en) 1986-08-28
IL80896A0 (en) 1987-03-31
GR77900B (no) 1984-09-25
DE3381761D1 (de) 1990-08-30
KR840003420A (ko) 1984-09-08
ES8406199A1 (es) 1984-08-01
NO172745C (no) 1993-09-01
IE830332L (en) 1983-08-18
EP0101506A1 (en) 1984-02-29
WO1983002897A1 (en) 1983-09-01
IL80895A (en) 1990-02-09
AU1339683A (en) 1983-09-08
EP0101506B1 (en) 1990-07-25
IL80896A (en) 1990-02-09
PH25689A (en) 1991-09-04
ES519875A0 (es) 1984-08-01
FI864102A0 (fi) 1986-10-10
EP0101506A4 (en) 1984-07-06
DK479083D0 (da) 1983-10-17
FI833768A (fi) 1983-10-17
JPH0797396A (ja) 1995-04-11
DK172619B1 (da) 1999-03-01
US4762708A (en) 1988-08-09
FI73885B (fi) 1987-08-31
IL80895A0 (en) 1987-03-31
JP2567202B2 (ja) 1996-12-25
FI73885C (fi) 1987-12-10
IL67930A (en) 1990-02-09
IE56479B1 (en) 1991-08-14
FI83880B (fi) 1991-05-31
ATE54827T1 (de) 1990-08-15

Similar Documents

Publication Publication Date Title
NO842962L (no) Fremgangsmaate for fremstilling av et polypeptid egnet for anvendelse i en vaksinasjonsprosedyre
NO843592L (no) Fremgangsmaate for fremstilling av et polypeptid
NO167673C (no) Fremgangsmaate for fremstilling av et polypeptid.
ES557048A0 (es) Procedimiento para preparar peptidos triofluormetilcetona-sustituidos
JPS54149294A (en) Patient transporter
DK165479C (da) Madras
ES526524A0 (es) Un procedimiento para preparar un complejo inmunogenico que contiene proteinas o peptidos antigenicos
DK271482A (da) Fremgangsmaade til fremstilling af et polypeptid
GB2034717B (en) Method for preparing recombinant
IT1120728B (it) Apparecchio per la respirazione artificiale in particolare per bambini
RO88702A (ro) Procedeu pentru prepararea peptidelor
ES543973A0 (es) Procedimiento para preparar peptidos
ZA835014B (en) Avian proventriculitis vaccine
MX160995A (es) Procedimiento para prepara peptidos
DK551287A (da) Polypeptid
DK354389D0 (da) Polypeptid
ES535455A0 (es) Un procedimiento para preparar peptidos
DK410481A (da) Fremgangsmaade til fremstilling af et polypeptid
IT1164639B (it) Perfezionamento nelle sedie a rotelle
GB2023416B (en) Therapeutic chair
HUT39362A (en) Process for preparing polypeptide vaccine
AR241015A1 (es) "procedimiento para preparar acidos 16-fenoxiprostatrienoicos"
NO832148L (no) Fremgangsmaate for fremstilling av et farmakologisk aktivt polypeptid
DK492588D0 (da) Antigen-polypeptider
JPS5589231A (en) Vaccine

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2002